New York State Common Retirement Fund’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-64
| Closed | -$1K | – | 3276 |
|
2024
Q2 | $1K | Sell |
64
-1,346
| -95% | -$21K | ﹤0.01% | 3296 |
|
2024
Q1 | $32K | Buy |
1,410
+118
| +9% | +$2.68K | ﹤0.01% | 3080 |
|
2023
Q4 | $17K | Sell |
1,292
-19
| -1% | -$250 | ﹤0.01% | 3165 |
|
2023
Q3 | $26K | Buy |
1,311
+47
| +4% | +$932 | ﹤0.01% | 3156 |
|
2023
Q2 | $34K | Sell |
1,264
-8
| -0.6% | -$215 | ﹤0.01% | 3194 |
|
2023
Q1 | $74K | Sell |
1,272
-2,000
| -61% | -$116K | ﹤0.01% | 2894 |
|
2022
Q4 | $167K | Sell |
3,272
-1,222
| -27% | -$62.4K | ﹤0.01% | 2799 |
|
2022
Q3 | $368K | Buy |
4,494
+1,236
| +38% | +$101K | ﹤0.01% | 2493 |
|
2022
Q2 | $220K | Sell |
3,258
-237
| -7% | -$16K | ﹤0.01% | 2757 |
|
2022
Q1 | $386K | Buy |
3,495
+655
| +23% | +$72.3K | ﹤0.01% | 2513 |
|
2021
Q4 | $274K | Sell |
2,840
-11
| -0.4% | -$1.06K | ﹤0.01% | 2753 |
|
2021
Q3 | $249K | Sell |
2,851
-1,102
| -28% | -$96.2K | ﹤0.01% | 2831 |
|
2021
Q2 | $612K | Sell |
3,953
-1,039
| -21% | -$161K | ﹤0.01% | 2487 |
|
2021
Q1 | $788K | Sell |
4,992
-366
| -7% | -$57.8K | ﹤0.01% | 2226 |
|
2020
Q4 | $1.24M | Hold |
5,358
| – | – | ﹤0.01% | 1941 |
|
2020
Q3 | $1.17M | Sell |
5,358
-429
| -7% | -$93.9K | ﹤0.01% | 1832 |
|
2020
Q2 | $1.64M | Buy |
5,787
+1,725
| +42% | +$490K | ﹤0.01% | 1614 |
|
2020
Q1 | $1.17M | Hold |
4,062
| – | – | ﹤0.01% | 1655 |
|
2019
Q4 | $1.17M | Buy |
4,062
+122
| +3% | +$35.1K | ﹤0.01% | 1881 |
|
2019
Q3 | $569K | Buy |
3,940
+973
| +33% | +$141K | ﹤0.01% | 2264 |
|
2019
Q2 | $267K | Hold |
2,967
| – | – | ﹤0.01% | 2678 |
|
2019
Q1 | $260K | Hold |
2,967
| – | – | ﹤0.01% | 2598 |
|
2018
Q4 | $417K | Sell |
2,967
-626
| -17% | -$88K | ﹤0.01% | 2366 |
|
2018
Q3 | $918K | Hold |
3,593
| – | – | ﹤0.01% | 2137 |
|
2018
Q2 | $916K | Buy |
3,593
+1,080
| +43% | +$275K | ﹤0.01% | 2147 |
|
2018
Q1 | $506K | Buy |
2,513
+480
| +24% | +$96.6K | ﹤0.01% | 2347 |
|
2017
Q4 | $293K | Hold |
2,033
| – | – | ﹤0.01% | 2594 |
|
2017
Q3 | $335K | Buy |
2,033
+153
| +8% | +$25.2K | ﹤0.01% | 2555 |
|
2017
Q2 | $255K | Buy |
1,880
+473
| +34% | +$64.2K | ﹤0.01% | 2723 |
|
2017
Q1 | $271K | Sell |
1,407
-555
| -28% | -$107K | ﹤0.01% | 2650 |
|
2016
Q4 | $277K | Sell |
1,962
-484
| -20% | -$68.3K | ﹤0.01% | 2650 |
|
2016
Q3 | $357K | Sell |
2,446
-18
| -0.7% | -$2.63K | ﹤0.01% | 2491 |
|
2016
Q2 | $248K | Sell |
2,464
-2,951
| -54% | -$297K | ﹤0.01% | 2628 |
|
2016
Q1 | $725K | Hold |
5,415
| – | – | ﹤0.01% | 2098 |
|
2015
Q4 | $1.08M | Hold |
5,415
| – | – | ﹤0.01% | 1926 |
|
2015
Q3 | $855K | Buy |
5,415
+602
| +13% | +$95.1K | ﹤0.01% | 2036 |
|
2015
Q2 | $1.96M | Buy |
+4,813
| New | +$1.96M | ﹤0.01% | 1863 |
|